SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000863894-24-000011
Filing Date
2024-05-08
Accepted
2024-05-08 13:09:33
Documents
81
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q veru-20240331x10q.htm   iXBRL 10-Q 3093049
2 EX-31.1 veru-20240331xex31_1.htm EX-31.1 15748
3 EX-31.2 veru-20240331xex31_2.htm EX-31.2 15973
4 EX-32.1 veru-20240331xex32_1.htm EX-32.1 11946
  Complete submission text file 0000863894-24-000011.txt   11904177

Data Files

Seq Description Document Type Size
5 EX-101.SCH veru-20240331.xsd EX-101.SCH 60981
6 EX-101.CAL veru-20240331_cal.xml EX-101.CAL 60305
7 EX-101.DEF veru-20240331_def.xml EX-101.DEF 225375
8 EX-101.LAB veru-20240331_lab.xml EX-101.LAB 435987
9 EX-101.PRE veru-20240331_pre.xml EX-101.PRE 398041
85 EXTRACTED XBRL INSTANCE DOCUMENT veru-20240331x10q_htm.xml XML 2682906
Mailing Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127
Business Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

IRS No.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-13602 | Film No.: 24925118
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)